VEGFA and age-related macular degeneration: Moreover, anti-VEGF therapy may result in the temporary regression of neovascular vessels in AMD, it also triggers tissue hypoxia and neovascular vessel regeneration, causing gradual tissue damage due to CNV's fragile intercellular adhesion, high permeability, and leakage of pro-inflammatory factors into the surrounding tissues.